Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | EC50 | = | 126.4 | ug/ml | 15844966 | |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 4466.8 | nM | PubChem BioAssay data set |
NPT53 | Individual Protein | 4'-phosphopantetheinyl transferase ffp | Bacillus subtilis | Potency | = | 89125.1 | nM | PubChem BioAssay data set |
NPT60 | Individual Protein | Lysosomal alpha-glucosidase | Homo sapiens | Potency | = | 50118.7 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | > | 118549 | nM | PubChem BioAssay data set | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT2625 | Protein Complex | Exodeoxyribonuclease V | Escherichia coli (strain K12) | IC50 | > | 118549 | nM | PubChem BioAssay data set |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 18526 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 1636 | nM | PubChem BioAssay data set | |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 3981.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 20596.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 23109.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7943.3 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC292299 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC34838 |
0.9818 | High Similarity | NPC263207 |
0.9153 | High Similarity | NPC262615 |
0.871 | High Similarity | NPC250953 |
0.871 | High Similarity | NPC306696 |
0.7903 | Intermediate Similarity | NPC105297 |
0.7656 | Intermediate Similarity | NPC128559 |
0.6329 | Remote Similarity | NPC84128 |
0.6329 | Remote Similarity | NPC53858 |
0.629 | Remote Similarity | NPC471131 |
0.6154 | Remote Similarity | NPC31756 |
0.6076 | Remote Similarity | NPC476243 |
0.6076 | Remote Similarity | NPC476156 |
0.6076 | Remote Similarity | NPC476137 |
0.6076 | Remote Similarity | NPC476117 |
0.6 | Remote Similarity | NPC476302 |
0.5926 | Remote Similarity | NPC6902 |
0.5926 | Remote Similarity | NPC184473 |
0.5897 | Remote Similarity | NPC59867 |
0.5867 | Remote Similarity | NPC214532 |
0.5867 | Remote Similarity | NPC196007 |
0.5867 | Remote Similarity | NPC76297 |
0.5833 | Remote Similarity | NPC84182 |
0.5833 | Remote Similarity | NPC128005 |
0.5802 | Remote Similarity | NPC23984 |
0.5802 | Remote Similarity | NPC475542 |
0.5789 | Remote Similarity | NPC33721 |
0.5783 | Remote Similarity | NPC472351 |
0.5732 | Remote Similarity | NPC284456 |
0.5714 | Remote Similarity | NPC256312 |
0.5714 | Remote Similarity | NPC80350 |
0.5714 | Remote Similarity | NPC209156 |
0.5714 | Remote Similarity | NPC266888 |
0.5714 | Remote Similarity | NPC161774 |
0.5663 | Remote Similarity | NPC235078 |
0.5652 | Remote Similarity | NPC321536 |
0.5647 | Remote Similarity | NPC477539 |
0.5634 | Remote Similarity | NPC327252 |
0.5634 | Remote Similarity | NPC243964 |
0.5632 | Remote Similarity | NPC275715 |
0.56 | Remote Similarity | NPC126779 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC292299 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9153 | High Similarity | NPD6437 | Approved |
0.9153 | High Similarity | NPD6438 | Approved |
0.6338 | Remote Similarity | NPD322 | Phase 1 |
0.6154 | Remote Similarity | NPD4815 | Discontinued |
0.6061 | Remote Similarity | NPD9425 | Approved |
0.6024 | Remote Similarity | NPD7760 | Phase 2 |
0.6024 | Remote Similarity | NPD7759 | Phase 2 |
0.6 | Remote Similarity | NPD7763 | Phase 2 |
0.6 | Remote Similarity | NPD7762 | Phase 2 |
0.5909 | Remote Similarity | NPD1456 | Approved |
0.5833 | Remote Similarity | NPD3723 | Clinical (unspecified phase) |
0.5811 | Remote Similarity | NPD620 | Approved |
0.5802 | Remote Similarity | NPD612 | Discontinued |
0.5789 | Remote Similarity | NPD8576 | Approved |
0.5732 | Remote Similarity | NPD2683 | Discontinued |
0.5714 | Remote Similarity | NPD574 | Approved |
0.5714 | Remote Similarity | NPD8950 | Approved |
0.5682 | Remote Similarity | NPD4261 | Phase 1 |
0.5634 | Remote Similarity | NPD575 | Clinical (unspecified phase) |
0.56 | Remote Similarity | NPD4242 | Approved |
PubChem CID   | 14671620 |
ChEMBL   | CHEMBL517615 |
ZINC   |
Molecular Weight:   | 586.33 |
ALogP:   | -6.2283 |
MLogP:   | 2.67 |
XLogP:   | -0.247 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 219.39 |
# H-Bond Aceptor:   | 9 |
# H-Bond Donor:   | 6 |
# Rings:   | 1 |
# Heavy Atoms:   | 41 |